Under a new Centers for Medicare & Medicaid Services (CMS) regulation, some physician office-based labs (POL) will be required to report private-payer payment rates and the associated volumes of tests performed within a POL.
As of July 1, 2016, a Substance Use Disorder (SUD) benefit is available to New Hampshire's Medicaid recipients. The new benefit, previously offered only to those who enrolled in Medicaid two years ago, as part of the expansion program, can now be accessed by Medicaid recipients in the state’s fee-for-service plan or enrolled with either New Hampshire Healthy Families or the Well Sense Health Plan.
The State of New Hampshire recently released a notice of hearing on the receiver's motion for the approval of the assumption agreement with MedPro (a private insurer) as part of the New Hampshire Medical Malpractice Joint Underwriting Association (JUA) dissolution process.
The Merrimack Superior Court has scheduled a hearing on the Approval Motion at 1:30 pm on August 5, 2016, in Courtroom 1 at the Merrimack Superior Court, 163 North Main Street, Concord, NH 03302.
Effective September 1, 2016, physicians will need to include 3 hours of Board approved opioid CME or pass a test, as part of the regular every-other year CME reporting cycle that coincides with license renewal. Opioid-related online CME courses: https://www.nh.gov/medicine/
The NH DHHS issued a health alert on May 23, regarding Lyme Disease and Other Tickborne Diseases in New Hampshire.
NH Division of Public Health Services (NH DPHS) draws your attention to the following:
Key Points and Recommendations:
1. NH continues to have one of the highest rates of Lyme disease in the nation and ~60% of blacklegged ticks sampled in NH are infected with Borrelia burgdorferi, the bacterium that causes Lyme disease.